The store will not work correctly when cookies are disabled.
N-(3-(2-Amino-5-methoxyphenyl)-3-oxopropyl)-4-chlorobenzimidamide
ID: ALA4868600
PubChem CID: 164622839
Max Phase: Preclinical
Molecular Formula: C17H18ClN3O2
Molecular Weight: 331.80
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(N)c(C(=O)CCNC(=N)c2ccc(Cl)cc2)c1
Standard InChI: InChI=1S/C17H18ClN3O2/c1-23-13-6-7-15(19)14(10-13)16(22)8-9-21-17(20)11-2-4-12(18)5-3-11/h2-7,10H,8-9,19H2,1H3,(H2,20,21)
Standard InChI Key: SFCDYSPXFWZQRF-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
26.9210 -12.2998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9123 -11.4827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6323 -12.7014 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2184 -12.7153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5070 -12.3138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8044 -12.7293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8090 -13.5464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5245 -13.9480 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.1064 -13.9661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1151 -14.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4125 -15.1988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7012 -14.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6925 -13.9801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3951 -13.5646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8264 -15.1807 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9835 -13.5778 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2802 -13.9938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6166 -11.0675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6082 -10.2512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8957 -9.8493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1901 -10.2699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2019 -11.0848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8859 -9.0322 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
6 7 1 0
7 8 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
10 15 1 0
7 9 1 0
4 5 1 0
16 17 1 0
13 16 1 0
2 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 2 1 0
20 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 331.80 | Molecular Weight (Monoisotopic): 331.1088 | AlogP: 3.12 | #Rotatable Bonds: 6 |
Polar Surface Area: 88.20 | Molecular Species: BASE | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 11.06 | CX LogP: 2.91 | CX LogD: 0.52 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.33 | Np Likeness Score: -0.67 |
References
1. Arias F, Franco-Montalban F, Romero M, Carrión MD, Camacho ME.. (2021) Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors., 44 [PMID:34218000] [10.1016/j.bmc.2021.116294] |